Filing Details
- Accession Number:
- 0001562180-19-006260
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 10:12:56
- Reporting Period:
- 2019-12-23
- Accepted Time:
- 2019-12-26 10:12:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741281 | K. Christina Isacson | C/O Magenta Therapeutics, Inc. 100 Technology Square Cambridge MA 02139 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-23 | 9,867 | $16.03 | 88,249 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This trade is pursuant to an active 10b5-1 plan.
- This transaction was executed in multiple trades at prices ranging from $16.00 to $16.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
